Brand Names:
Cipro


Drug Type: Antibiotic

Ciprofloxacin (Cipro)


Ciprofloxacin (Cipro) is a broad-spectrum antiinfective agent of the fluoroquinolone class, which is useful for treating a wide range of bacterial infections. Baytril is the veterinary-labeled form of ciprofloxacin.

Fluroquinolone antibiotics are the drug of choice against Mycoplasma species, and most gram-negative bacteria, which includes Escherichia coli, and Salmonella; they aren't as effective against gram-positive bacteria. Due to its bitter taste, it may be necessary to mix the drug with another medium such as apple sauce or fruit juice to improve the taste. The drug is less effective when administered in drinking water.

Caution: Birds taking this medication should be concurrently monitored for signs of secondary infections, especially those caused by sour crop.
15-40 mg/kg PO, IM, IV q12h
  • Acetylsalicylic acid (Asprin): Acetylsalicylic acid may increase the neuroexcitatory activities of Ciprofloxacin.
  • Calcium products: Calcium Acetate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
  • Calcium Acetate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
  • Carprofen: Carprofen may increase the neuroexcitatory activities of Ciprofloxacin.
  • Corticosterone: The risk or severity of adverse effects can be increased when Corticosterone is combined with Ciprofloxacin.
  • Curcumin: Curcumin may increase the neuroexcitatory activities of Ciprofloxacin.
  • Dexamethasone:The risk or severity of adverse effects can be increased when Dexamethasone is combined with Ciprofloxacin.
  • Diclofenac:Diclofenac may increase the neuroexcitatory activities of Ciprofloxacin.
  • Digitoxin: Digitoxin may decrease the cardiotoxic activities of Ciprofloxacin.
  • Digoxin: Digoxin may decrease the cardiotoxic activities of Ciprofloxacin.
  • Enalapril: The risk or severity of ventricular arrhythmias can be increased when Enalapril is combined with Ciprofloxacin.
  • Erythromycin: Erythromycin may increase the QTc-prolonging activities of Ciprofloxacin.
  • Etodolac: Etodolac may increase the neuroexcitatory activities of Ciprofloxacin.
  • Evening primrose oil:Evening primrose oil may increase the neuroexcitatory activities of Ciprofloxacin.
  • Fluconazole:Fluconazole may increase the QTc-prolonging activities of Ciprofloxacin.
  • Flunixin: Flunixin may increase the neuroexcitatory activities of Ciprofloxacin.
  • Hydrocortisone: The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Ciprofloxacin.
  • Iron: The serum concentration of Ciprofloxacin can be decreased when it is combined with Iron.
  • Isoflurane:Isoflurane may increase the QTc-prolonging activities of Ciprofloxacin.
  • Itraconazole: Itraconazole may increase the QTc-prolonging activities of Ciprofloxacin.
  • Ketoconazole: Ketoconazole may increase the QTc-prolonging activities of Ciprofloxacin.
  • Ketoprofen: Ketoprofen may increase the neuroexcitatory activities of Ciprofloxacin.
  • Leuprolide: Leuprolide may increase the QTc-prolonging activities of Ciprofloxacin.
  • Magnesium sulfate: The serum concentration of Ciprofloxacin can be decreased when it is combined with Magnesium sulfate.
  • Meloxicam: Meloxicam may increase the neuroexcitatory activities of Ciprofloxacin.
  • Methylprednisolone: The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Ciprofloxacin.
  • Oxytocin: Oxytocin may increase the QTc-prolonging activities of Ciprofloxacin.
  • Pergolide: The risk or severity of adverse effects can be increased when Pergolide is combined with Ciprofloxacin.
  • Phenylbutazone: Phenylbutazone may increase the neuroexcitatory activities of Ciprofloxacin.
  • Prednisolone:The risk or severity of adverse effects can be increased when Prednisolone is combined with Ciprofloxacin.
  • Prednisone: The risk or severity of adverse effects can be increased when Prednisone is combined with ciprofloxacin.
  • Resveratrol:Resveratrol may increase the neuroexcitatory activities of Ciprofloxacin.
  • Sodium bicarbonate:Sodium bicarbonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
  • Sulfadiazine:Ciprofloxacin may increase the hypoglycemic activities of Sulfadiazine
  • Sulfamethoxazole:Sulfamethoxazole may increase the QTc-prolonging activities of Ciprofloxacin.
  • Tamoxifen:Tamoxifen may increase the QTc-prolonging activities of Ciprofloxacin.
  • Trimethoprim:Trimethoprim may increase the QTc-prolonging activities of Ciprofloxacin.
  • Voriconazole: Voriconazole may increase the QTc-prolonging activities of Ciprofloxacin.
  • Xanthinol:The serum concentration of Xanthinol can be increased when it is combined with Ciprofloxacin.